Related Experiment Video
Updated: Sep 27, 2025
08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.3K
Fibromyalgia: Recognition and Management in the Primary Care Office
1Case Western Reserve Cleveland Clinic School of Medicine, Cleveland, OH, USA.
Rheumatic Diseases Clinics of North America
|April 11, 2022
Summary
Fibromyalgia is a chronic pain disorder causing widespread pain, fatigue, and cognitive issues for over three months. Treatment requires an individualized approach focusing on mood, sleep, exercise, and stress management.
Area of Science:
- Rheumatology
- Pain Medicine
- Neurology
Background:
- Fibromyalgia is a complex chronic pain condition.
- It is characterized by widespread pain lasting at least three months.
- Associated symptoms include fatigue, sleep disturbances, and cognitive difficulties.
Purpose of the Study:
- To provide an overview of fibromyalgia.
- To highlight common associated conditions.
- To outline current treatment strategies.
Main Methods:
- Literature review of fibromyalgia diagnosis and management.
- Synthesis of current understanding of the condition.
- Emphasis on individualized treatment plans.
Main Results:
- Fibromyalgia presents with chronic generalized pain, fatigue, and cognitive issues.
- Commonly co-occurring conditions include irritable bowel syndrome and mood disorders.
- Women are disproportionately affected.
Conclusions:
- Fibromyalgia management requires a multidisciplinary and individualized approach.
- Treatment should address mood disorders, sleep quality, and physical activity.
- Coping strategies for pain and stress are crucial for patient well-being.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
894
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
894
01:31Skeletal Muscle Relaxants: Therapeutic Uses
654
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
654
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.8K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.8K
01:28Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
01:21Skeletal Muscle Relaxants: Adverse Effects
504
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
504